Filtered By:
Drug: Baclofen
Therapy: Physiotherapy

This page shows you your search results in order of date.

Order by Relevance | Date

Total 16 results found since Jan 2013.

Spasticity treatment in Norwegian hospitals
The objective of the study was to obtain an overview of the availability and organisation of these specialised forms of spasticity treatment in Norway.MATERIAL AND METHOD: We conducted a survey in which a digital questionnaire was sent to hospitals that offer spasticity treatment.RESULTS: A total of 30 of 47 hospital departments/outpatient clinics (hereafter referred to as 'hospital units') distributed across all Norwegian health regions responded to the questionnaire. Spasticity treatment with botulinum toxin and baclofen pump was available in all of the health regions. Median time from first referral was 10 weeks (interq...
Source: Tidsskrift for den Norske Laegeforening - September 5, 2023 Category: General Medicine Authors: Kristin Østlie Jelena Simic Tiina Rekand Source Type: research

A Systematic Review of the Interventions for Management of Pain in Patients After Spinal Cord Injury
In conclusion, several pharmaceutical and non-pharmaceutical methods exist, which can reduce pain in patients after SCI. The type of intervention can be considered by the physician depending on the patients' preference, age, medical history, type of pain, and associated symptoms. However, more studies with greater samples and with better methodological quality should be conducted.PMID:37644939 | PMC:PMC10461890 | DOI:10.7759/cureus.42657
Source: Pain Physician - August 30, 2023 Category: Anesthesiology Authors: Ioannis Koukoulithras Abdulaziz Alkhazi Athanasios Gkampenis Alexandra Stamouli Minas Plexousakis Gianna Drousia Eleana Xanthi Charis Roussos Spyridon Kolokotsios Source Type: research

Tizanidine induced hypotension: report of a case and review of literature
CONCLUSION: This patient highlights the need for close monitoring of patients receiving tizanidine co-medication with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers. These drugs have a synergistic effect on reducing the renin-angiotensin-aldosterone system, thereby hypotension and bradycardia.PMID:37489780 | DOI:10.2174/1574886318666230725113855
Source: Current Drug Safety - July 25, 2023 Category: Drugs & Pharmacology Authors: Roopali Mahajan Jayantee Kalita Source Type: research